iSonea Limited Adds Dr. David Dantzker to Board of Directors

Published: Mar 21, 2012

SEVERNA PARK, Md.--(BUSINESS WIRE)--Medical technology company iSonea Ltd. (ASX: ISN; OTCQX: ISOAY) today announced that David R. Dantzker, M.D., general partner at Wheatley Partners, LP, and former Chairman of Pulmonary Disease for the American Board of Internal Medicine, has joined iSonea’s Board of Directors (BOD).

Back to news